Article

Lupus: 5 Questions on Diagnosis

Brush up on the diagnosis of systemic lupus erythematosus with 5 questions based on the recent British Society for Rheumatology guidelines.

In January 2018, the British Society for Rheumatology published new guidelines for the diagnosis, monitoring, and treatment of non-renal manifestations of systemic lupus erythematosus (SLE) in adults.1 Here, we offer a 5-question quiz based on these guidelines that focuses on the diagnosis of lupus.

 

Question 1

Please click below for answer and next question.

ANSWER: C. 5%

A positive ANA test occurs in 5% of the adult population, and ANAs are present in 95% of patients with SLE.

 

Question 2

Please click below for answer and next question.

ANSWER: B. Women during the reproductive years

Although SLE can occur at any age, it most frequently presents in women during the reproductive years.

 

Question 3

Please click below for answer and next question.

ANSWER: A. True.

Survival may be improving, but life expectancy is still poor compared with the general population.

 

Question 4

Please click below for answer and next question.

ANSWER: D. Anti-Ro/La antibodies

The presence of anti-dsDNA antibodies, low complement levels, or anti-Smith (Sm) antibodies is highly predictive of SLE in patients with relevant clinical features. Anti-Ro/La and anti-RNP antibodies are less specific markers because they are found in other autoimmune rheumatic disorders as well as SLE.

 

Question 5

Please click below for answer.

ANSWER: A. True

All patients with lupus should be tested for antiphospholipids because their presence indicates an elevated risk of arterial/venous thrombotic events and adverse pregnancy outcomes. Confirmatory tests for antiphospholipid syndrome are positive lupus anticoagulant, anticardiolipin (IgG, IgM), and/or anti-beta-2 glycoprotein-1 (IgG, IgM) on 2 occasions at least 12 weeks apart.

 

For an overview of the highlights of the guidelines, please see Lupus Management Guidelines From the British Society for Rheumatology.

References:

1. Gordon C, Amissah-Arthur MB, Gayed M, et al, for the British Society for Rheumatology Standards, Audit and Guidelines Working Group. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology. 2018;57:e1-e45. doi: 10.1093/rheumatology/kex286.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.